Impact of Salusin-α and -β on Human Macrophage Foam Cell Formation and Coronary Atherosclerosis
暂无分享,去创建一个
M. Shichiri | K. Nose | T. Katagiri | Youichi Kobayashi | S. Koba | A. Miyazaki | T. Matsuyama | Kengo Sato | T. Sakai | H. Ota | Takuya Watanabe | T. Kanome | S. Hongo | K. Nishio
[1] Yan Chen,et al. Catalase potentiates retinoic acid‐induced THP‐1 monocyte differentiation into macrophage through inhibition of peroxisome proliferator‐activated receptor γ , 2007, Journal of leukocyte biology.
[2] S. Gardiner,et al. Reply to 'Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities' , 2007, Nature Medicine.
[3] T. Tateno,et al. Presence of immunoreactive salusin-α in human serum and urine , 2006, Peptides.
[4] T. V. van Berkel,et al. Regulation of cholesterol homeostasis in macrophages and consequences for atherosclerotic lesion development , 2006, FEBS letters.
[5] Lu Yan,et al. Salusins Protect Neonatal Rat Cardiomyocytes from Serum Deprivation-induced Cell Death Through Upregulation of GRP78 , 2006, Journal of cardiovascular pharmacology.
[6] M. Shichiri,et al. Salusin β is a surrogate ligand of the mas-like G protein-coupled receptor MrgA1 , 2006 .
[7] M. Adachi,et al. Serotonin acts as an up-regulator of acyl-coenzyme A:cholesterol acyltransferase-1 in human monocyte-macrophages. , 2006, Atherosclerosis.
[8] T. Katagiri,et al. Human Urotensin II as a Link between Hypertension and Coronary Artery Disease , 2006, Hypertension Research.
[9] M. Adachi,et al. Human Urotensin II Accelerates Foam Cell Formation in Human Monocyte-Derived Macrophages , 2005, Hypertension.
[10] M. Shichiri,et al. Synthetic Salusins as Cardiac Depressors in Rat , 2005, Hypertension.
[11] Jing Zhao,et al. Salusins promote cardiomyocyte growth but does not affect cardiac function in rats , 2004, Regulatory Peptides.
[12] Y. Sasaki,et al. Up-regulation of acyl-coenzyme A:cholesterol acyltransferase-1 by transforming growth factor-beta1 during differentiation of human monocytes into macrophages. , 2004, Biochemical and biophysical research communications.
[13] S. Kihara,et al. Adiponectin down-regulates acyl-coenzyme A:cholesterol acyltransferase-1 in cultured human monocyte-derived macrophages. , 2004, Biochemical and biophysical research communications.
[14] David Handelsman,et al. Dehydroepiandrosterone, an adrenal androgen, increases human foam cell formation: a potentially pro-atherogenic effect. , 2003, Journal of the American College of Cardiology.
[15] I. Toth,et al. Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. , 2003, American journal of physiology. Heart and circulatory physiology.
[16] T. Ota,et al. Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities , 2003, Nature Medicine.
[17] Zhi-jun Duan,et al. Synergistic Transcriptional Activation of HumanAcyl-coenzyme A: Cholesterol Acyltransterase-1 Gene by Interferon-γ and All-trans-Retinoic Acid THP-1 Cells* , 2001, The Journal of Biological Chemistry.
[18] Chunjiang Yu,et al. Roles of acyl-coenzyme A : cholesterol acyltransferase-1 and -2 , 2001, Current opinion in lipidology.
[19] G. Schmitz,et al. ATP-Binding Cassette Transporter A1 (ABCA1) in Macrophages: A Dual Function in Inflammation and Lipid Metabolism? , 2000, Pathobiology.
[20] F. Rengo,et al. Intracoronary serotonin release after high-pressure coronary stenting. , 1999, The American journal of cardiology.
[21] D. Duncker,et al. Cardiac interstitial fluid levels of angiotensin I and II in the pig. , 1999, Journal of hypertension.
[22] S Gordon,et al. Analysis of macrophage scavenger receptor (SR-A) expression in human aortic atherosclerotic lesions. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[23] S. Horiuchi,et al. Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[24] N. Abumrad,et al. Dexamethasone enhances accumulation of cholesteryl esters by human macrophages. , 1995, The American journal of physiology.
[25] C. Benedict,et al. Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. , 1986, Circulation.
[26] M. Shichiri. Reply to 'Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities' , 2007, Nature Medicine.